Drug Shortage Report for DEXTROSE INJECTION USP

Last updated on 2021-09-15 History
Report ID 143307
Drug Identification Number 00037915
Brand name DEXTROSE INJECTION USP
Common or Proper name 5% Dextrose Injection
Company Name ICU MEDICAL CANADA INC
Market Status MARKETED
Active Ingredient(s) DEXTROSE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250 mL
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-08-11
Actual start date 2021-08-30
Estimated end date 2021-09-17
Actual end date 2021-09-14
Shortage status Resolved
Updated date 2021-09-15
Company comments This issue has been resolved.
Health Canada comments
Contact Address 2600 BOUL ALFRED-NOBEL, SUITE 100
SAINT LAURENT, QUEBEC
CANADA H4S 0A9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2021-09-15 English Compare
v9 2021-09-14 French Compare
v8 2021-09-14 English Compare
v7 2021-09-07 French Compare
v6 2021-09-07 English Compare
v5 2021-08-16 French Compare
v4 2021-08-16 English Compare
v3 2021-08-12 English Compare
v2 2021-07-30 French Compare
v1 2021-07-30 English Compare